prof. dr. Karim Vermaelen

Journal Article
A1
open access

Circulating immune cell dynamics as outcome predictors for immunotherapy in non-small cell lung cancer

Alvaro Marcos Rubio (UGent) , Celine Everaert (UGent) , Eufra Van Damme (UGent) , Katleen De Preter (UGent) and Karim Vermaelen (UGent)

(2023) JOURNAL FOR IMMUNOTHERAPY OF CANCER. 11(8).

Add to list

Journal Article
A1
open access

Headspace volatile organic compound profiling of pleural mesothelioma and lung cancer cell lines as translational bridge for breath research

Eline Janssens, Zoë Mol (UGent) , Lore Vandermeersch (UGent) , Sabrina Lagniau (UGent) , Karim Vermaelen (UGent) , Jan Van Meerbeeck (UGent) , Christophe Walgraeve (UGent) , Elly Marcq and Kevin Lamote (UGent)

(2022) FRONTIERS IN ONCOLOGY. 12.

Add to list

Journal Article
A1
open access

Application of an ultrasensitive NGS-based blood test for the diagnosis of early-stage lung cancer : sensitivity, a hurdle still difficult to overcome

Malaïka Van der Linden (UGent) , Bram Van Gaever (UGent) , Lennart Raman, Karim Vermaelen (UGent) , Ingel Demedts (UGent) , Veerle Surmont (UGent) , Ulrike Himpe, Yolande Lievens (UGent) , Liesbeth Ferdinande (UGent) , Franceska Dedeurwaerdere, et al.

(2022) CANCERS. 14(8).

Add to list

Journal Article
A1
open access

Small-scale manufacturing of neoantigen-encoding messenger RNA for early-phase clinical trials

Joline Ingels (UGent) , Laurenz De Cock (UGent) , Rupert Mayer (UGent) , Pam Devreker (UGent) , Karin Weening (UGent) , Kelly Heyns (UGent) , Nele Lootens (UGent) , Saskia De Smet (UGent) , Marieke Brusseel (UGent) , Stijn De Munter (UGent) , et al.

(2022) CYTOTHERAPY. 24(2). p.213-222

Add to list

Miscellaneous

The RNA Atlas expands the catalog of human non-coding RNAs (June, 10.1038/s41587-021-00936-1, 2021)

Lucia Lorenzi, Hua-Sheng Chiu, Francisco Avila Cobos (UGent) , Stephen Gross, Pieter-Jan Volders (UGent) , Robrecht Cannoodt (UGent) , Justine Nuytens (UGent) , Katrien Vanderheyden, Jasper Anckaert (UGent) , Steve Lefever (UGent) , et al.

(2021) NATURE BIOTECHNOLOGY. 39(11). p.1467-1467

Add to list

Journal Article
A1
open access

Dendritic cell-based immunotherapy in lung cancer

Dieter Stevens (UGent) , Joline Ingels (UGent) , Sandra Van Lint (UGent) , Bart Vandekerckhove (UGent) and Karim Vermaelen (UGent)

(2021) FRONTIERS IN IMMUNOLOGY. 11.

Add to list

Journal Article
A2
open access

Afatinib for the treatment of advanced non-small-cell lung cancer harboring an epidermal growth factor receptor exon 18 E709_T710delinsD mutation : a case report

Lander Van Acker, Dieter Stevens (UGent) , Karim Vermaelen (UGent) and Veerle Surmont (UGent)

(2021) JOURNAL OF MEDICAL CASE REPORTS. 15(1).

Add to list

The RNA Atlas expands the catalog of human non-coding RNAs

Lucia Lorenzi, Hua-Sheng Chiu, Francisco Avila Cobos (UGent) , Stephen Gross, Pieter-Jan Volders (UGent) , Robrecht Cannoodt (UGent) , Justine Nuytens (UGent) , Katrien Vanderheyden, Jasper Anckaert (UGent) , Steve Lefever (UGent) , et al.

(2021) NATURE BIOTECHNOLOGY. 39(11). p.1453-1465

Add to list

Journal Article
A1
open access

mRNA in cancer immunotherapy : beyond a source of antigen

Lien Van Hoecke (UGent) , Rein Verbeke (UGent) , Heleen Dewitte (UGent) , Ine Lentacker (UGent) , Karim Vermaelen (UGent) , Karine Breckpot and Sandra Van Lint (UGent)

(2021) MOLECULAR CANCER. 20(1).

Add to list

Managing viral hepatitis in cancer patients under immune checkpoint inhibitors : should we take the risk?

Stijn De Keukeleire (UGent) , Tijl Vermassen (UGent) , Zahra Mosala Nezhad, Tessa Kerre (UGent) , Vibeke Kruse (UGent) , Hans Van Vlierberghe (UGent) , Karim Vermaelen (UGent) and Sylvie Rottey (UGent)

(2021) IMMUNOTHERAPY. 13(5). p.409-418

Academic Bibliography

prof. dr. Karim Vermaelen

Circulating immune cell dynamics as outcome predictors for immunotherapy in non-small cell lung cancer

Headspace volatile organic compound profiling of pleural mesothelioma and lung cancer cell lines as translational bridge for breath research

Application of an ultrasensitive NGS-based blood test for the diagnosis of early-stage lung cancer : sensitivity, a hurdle still difficult to overcome

Small-scale manufacturing of neoantigen-encoding messenger RNA for early-phase clinical trials

The RNA Atlas expands the catalog of human non-coding RNAs (June, 10.1038/s41587-021-00936-1, 2021)

Dendritic cell-based immunotherapy in lung cancer

Afatinib for the treatment of advanced non-small-cell lung cancer harboring an epidermal growth factor receptor exon 18 E709_T710delinsD mutation : a case report

The RNA Atlas expands the catalog of human non-coding RNAs

mRNA in cancer immunotherapy : beyond a source of antigen

Managing viral hepatitis in cancer patients under immune checkpoint inhibitors : should we take the risk?

Contents

Support

Contact